Variable | Overall PTC(n = 943) | PTC > 10 mm(n = 373) | PTMC(n = 570) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Yes | No | Uni- and multivariate analysis | Yes | No | Uni- and multivariate analysis | Yes | No | Uni- and multivariate analysis | |||||||
n(%) | n(%) | P | P | OR(95CI) | n(%) | n(%) | P | P | OR(95CI) | n(%) | n(%) | P | P | OR(95CI) | |
Gender | |||||||||||||||
 Male | 166(71) | 67(29) | < 0.001 | < 0.001 | 0.41 (0.28–0.58) | 90(84) | 17(16) | 0.004 | 0.02 | 0.48 (0.26–0.88) | 76(60) | 50(40) | < 0.001 | < 0.001 | 0.37 (0.24–0.57) |
 Female | 339(48) | 371(52) | 185(70) | 81(30) | 154(35) | 290(65) | |||||||||
Age (years) * | 43.6 ± 12.2 | 47.2 ± 9.8 | < 0.001 | < 0.001 | 0.97 (0.96–0.98) | 43.4 ± 12.6 | 49.2 ± 9.1 | < 0.001 | < 0.001 | 0.96 (0.94–0.98) | 43.9 ± 11.7 | 46.6 ± 10.0 | 0.001 | 0.01 | 0.98 (0.96–0.99) |
Tumor size (mm)* | 1.5 ± 1.1 | 0.9 ± 0.7 | < 0.001 | < 0.001 | 3.45 (2.48–4.79) | 2.1 ± 0.8 | 1.8 ± 0.8 | 0.01 | 0.02 | 1.49 (1.08–2.06) | 0.7 ± 0.2 | 0.6 ± 0.2 | 0.002 | 0.002 | 3.65 (1.62–8.21) |
Focality | |||||||||||||||
 Uni | 355(52) | 333(48) | 0.055 |  |  | 186(72) | 73(28) | 0.206 |  |  | 169(39) | 260(61) | 0.417 |  |  |
 Multi | 150(59) | 105(41) |  |  | 89(78) | 25(22) |  |  | 61(43) | 80(57) |  |  | |||
HT | |||||||||||||||
 No | 491(55) | 402(45) | < 0.001 | 0.03 | 0.42 (0.19–0.91) | 270(75) | 88(25) | < 0.001 | 0.006 | 0.21 (0.07–0.64) | 221(41) | 314(59) | 0.068 |  |  |
 Yes | 14(28) | 36(72) | 5(33) | 10(67) | 9(26) | 26(74) |  |  | |||||||
T staging | |||||||||||||||
 T1 | 418(50) | 420(50) | < 0.001 | < 0.001 | 4.94 (2.84–8.59) | 188(70) | 80(30) | 0.01 | 0.723 |  | 230(40) | 340(60) | – |  |  |
 T2 + T3 | 87(83) | 18(17) | 87(83) | 18(17) |  | 0 | 0 |  |  | ||||||
BRAFV600E mutation | |||||||||||||||
 No | 75(62) | 62(38) | 0.742 |  |  | 51(82) | 11(17) | 0.095 |  |  | 25(40) | 50(60) | 0.121 |  |  |
 Yes | 430(36) | 376(64) |  |  | 224(72) | 87(28) |  |  | 205(41) | 290(59) |  |  |